Inference

Inference Inc. is a privately-held, US-based biometrics service provider founded in 2017, offering full-spectrum support for clinical trials from design through regulatory submission. Its core expertise lies in biostatistics, independent statistical center operations for DMCs, and end-to-end data management, serving as a functional service provider (FSP) or project-based partner. With over 100 professionals and experience in 125+ clinical studies, the company helps sponsors navigate complex regulatory landscapes, particularly in pivotal trials, to drive confident and timely development decisions. While not developing its own therapeutics, it leverages AI/ML and digital health sectors to enhance clinical data analysis and operational efficiency.

Integrated biometrics service suite specializing in biostatistics, independent statistical center for DMC support, data management, and regulatory submission services. Leverages statistical methodologies (e.g., Estimand Framework) and likely incorporates AI/ML for clinical data analysis.

Inference competes in the biometrics services segment against large, full-service global CROs (e.g., IQVIA, Parexel, PPD) and a fragmented landscape of smaller, specialized biostatistics and data management CROs. Its differentiation lies in its focused expertise on independent DMC support and regulatory strategy, positioning it as a high-touch, expert partner rather than a volume-driven service provider.